Bionano Genomics, Inc. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BNGOU and buy or sell other stocks, ETFs, and their options commission-free!About BNGOU
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
CEORobert Erik Holmlin, PhD, MBA
CEORobert Erik Holmlin, PhD, MBA
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2003
Founded2003
Employees—
Employees—
BNGOU Key Statistics
Market cap75.49M
Market cap75.49M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume25.31K
Average volume25.31K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.00
52 Week high$8.00
52 Week low$5.40
52 Week low$5.40
Stock Snapshot
With a market cap of 75.49M, Bionano Genomics, Inc. Unit(BNGOU) trades at $7.38.
On 2025-12-14, Bionano Genomics, Inc. Unit(BNGOU) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 25.31K.
The stock's 52-week range extends from a low of $5.40 to a high of $8.00.
The stock's 52-week range extends from a low of $5.40 to a high of $8.00.